These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 16780545)
1. Soluble HLA-G expression and renal graft acceptance. Qiu J; Terasaki PI; Miller J; Mizutani K; Cai J; Carosella ED Am J Transplant; 2006 Sep; 6(9):2152-6. PubMed ID: 16780545 [TBL] [Abstract][Full Text] [Related]
2. Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure. Mizutani K; Terasaki P; Rosen A; Esquenazi V; Miller J; Shih RN; Pei R; Ozawa M; Lee J Am J Transplant; 2005 Sep; 5(9):2265-72. PubMed ID: 16095508 [TBL] [Abstract][Full Text] [Related]
3. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation. Rebmann V; Bartsch D; Wunsch A; Möllenbeck P; Golda T; Viebahn R; Grosse-Wilde H Hum Immunol; 2009 Dec; 70(12):995-9. PubMed ID: 19651178 [TBL] [Abstract][Full Text] [Related]
4. Analysis of HLA-G expression in serum and biopsy samples of kidney transplant recipients. Poláková K; Bandžuchová H; Žilinská Z; Chreňová S; Kuba D; Russ G Immunobiology; 2015 Apr; 220(4):533-7. PubMed ID: 25468563 [TBL] [Abstract][Full Text] [Related]
5. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation. Lee PC; Ozawa M Clin Transpl; 2007; ():219-26. PubMed ID: 18642453 [TBL] [Abstract][Full Text] [Related]
6. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss. Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503 [TBL] [Abstract][Full Text] [Related]
7. Detection of soluble HLA-G and its correlation with kidney transplant outcome. Kaneku H Clin Transpl; 2006; ():447-54. PubMed ID: 18365402 [TBL] [Abstract][Full Text] [Related]
8. Soluble MHC class I antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients. Zavazava N; Böttcher H; Ruchholtz WM Tissue Antigens; 1993 Jul; 42(1):20-6. PubMed ID: 8248891 [TBL] [Abstract][Full Text] [Related]
9. Antibodies against MICA antigens and kidney-transplant rejection. Zou Y; Stastny P; Süsal C; Döhler B; Opelz G N Engl J Med; 2007 Sep; 357(13):1293-300. PubMed ID: 17898098 [TBL] [Abstract][Full Text] [Related]
10. Association of kidney transplant failure and antibodies against MICA. Mizutani K; Terasaki P; Bignon JD; Hourmant M; Cesbron-Gautier A; Shih RN; Pei R; Lee J; Ozawa M Hum Immunol; 2006 Sep; 67(9):683-91. PubMed ID: 17002898 [TBL] [Abstract][Full Text] [Related]
11. Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: possible implications for monitoring patients. Creput C; Le Friec G; Bahri R; Amiot L; Charpentier B; Carosella E; Rouas-Freiss N; Durrbach A Hum Immunol; 2003 Nov; 64(11):1033-8. PubMed ID: 14602232 [TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA. Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633 [TBL] [Abstract][Full Text] [Related]
13. Antibodies to HLA-E may account for the non-donor-specific anti-HLA class-Ia antibodies in renal and liver transplant recipients. Ravindranath MH; Pham T; Ozawa M; Terasaki PI Int Immunol; 2012 Jan; 24(1):43-57. PubMed ID: 22190577 [TBL] [Abstract][Full Text] [Related]
14. Association of soluble human leukocyte antigen-G with acute tubular necrosis in kidney transplant recipients. Krongvorakul J; Kantachuvesiri S; Ingsathit A; Rattanasiri S; Mongkolsuk T; Kitpoka P; Thammanichanond D Asian Pac J Allergy Immunol; 2015 Jun; 33(2):117-22. PubMed ID: 26141032 [TBL] [Abstract][Full Text] [Related]
15. Complement-fixing antibodies against denatured HLA and MICA antigens are associated with antibody mediated rejection. Cai J; Terasaki PI; Zhu D; Lachmann N; Schönemann C; Everly MJ; Qing X Exp Mol Pathol; 2016 Feb; 100(1):45-50. PubMed ID: 26615783 [TBL] [Abstract][Full Text] [Related]
16. Allosensitization to HLA and MICA is an important measure of renal graft outcome. Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK Clin Transpl; 2007; ():211-7. PubMed ID: 18637472 [TBL] [Abstract][Full Text] [Related]
17. The association of HLA-G polymorphisms and the synergistic effect of sMICA and sHLA-G with chronic kidney disease and allograft acceptance. Hauer V; Risti M; Miranda BLM; da Silva JS; Cidral AL; Pozzi CM; Contieri FLC; Sadissou IA; Donadi EA; Augusto DG; Bicalho MDG PLoS One; 2019; 14(2):e0212750. PubMed ID: 30794652 [TBL] [Abstract][Full Text] [Related]
18. Dendritic cells secrete the immunosuppressive HLA-G molecule upon CTLA4-Ig treatment: implication in human renal transplant acceptance. Bahri R; Naji A; Menier C; Charpentier B; Carosella ED; Rouas-Freiss N; Durrbach A J Immunol; 2009 Dec; 183(11):7054-62. PubMed ID: 19915057 [TBL] [Abstract][Full Text] [Related]
19. Soluble HLA class I molecules exert differentiated influence on renal graft condition. Chudyk A; Masiuk M; Myślak M; Domański L; Sieńko J; Sulikowski T; Machaliński B; Giedrys-Kalemba S Transplant Proc; 2006; 38(1):90-3. PubMed ID: 16504672 [TBL] [Abstract][Full Text] [Related]
20. Detection of soluble HLA-G molecules in plasma and amniotic fluid. Rebmann V; Pfeiffer K; Pässler M; Ferrone S; Maier S; Weiss E; Grosse-Wilde H Tissue Antigens; 1999 Jan; 53(1):14-22. PubMed ID: 10082427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]